Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin.
Dailey, G E
Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin. [electronic resource] - Diabetes, obesity & metabolism Dec 2013 - 1085-92 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1463-1326
10.1111/dom.12131 doi
Analysis of Variance
Blood Glucose--metabolism
Diabetes Mellitus, Type 2--blood
Female
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--blood
Hypoglycemic Agents--therapeutic use
Insulin Glargine
Insulin, Isophane--therapeutic use
Insulin, Long-Acting--therapeutic use
Male
Middle Aged
Randomized Controlled Trials as Topic
Risk Factors
Time Factors
Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin. [electronic resource] - Diabetes, obesity & metabolism Dec 2013 - 1085-92 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1463-1326
10.1111/dom.12131 doi
Analysis of Variance
Blood Glucose--metabolism
Diabetes Mellitus, Type 2--blood
Female
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--blood
Hypoglycemic Agents--therapeutic use
Insulin Glargine
Insulin, Isophane--therapeutic use
Insulin, Long-Acting--therapeutic use
Male
Middle Aged
Randomized Controlled Trials as Topic
Risk Factors
Time Factors